Reporting vaccine-associated paralytic poliomyelitis : Concordance between the CDC and the National Vaccine Injury Compensation Program.
This paper compares cases of paralytic poliomyelitis reported to the systems operated by the National Vaccine Injury Compensation Program and the Centers for Disease Control and Prevention (CDC) for reporting of adverse events associated with vaccination.
Of the 118 cases of vaccine-associated paralytic poliomyelitis determined by either system, 18 were reported initially only to the CDC, and 50 to both.
The annual incidence of vaccine-associated paralytic poliomyelitis determined from data from both systems varied from 6 to 13 case (mean=9.1) a year, with an increase of 1.4 cases a year when initial reports only to the compensation program are included.
Thus, the compensation program provides important supplemental incidence data.
Mots-clés Pascal : Poliomyélite antérieure, Virose, Infection, Toxicité, Vaccin, Complication, Diagnostic, Etude comparative, Surveillance sanitaire, Etats Unis, Amérique du Nord, Amérique, Incidence, Homme, Système nerveux pathologie, Système nerveux central pathologie, Moelle épinière pathologie, Déclaration maladie
Mots-clés Pascal anglais : Acute anterior poliomyelitis, Viral disease, Infection, Toxicity, Vaccine, Complication, Diagnosis, Comparative study, Sanitary surveillance, United States, North America, America, Incidence, Human, Nervous system diseases, Central nervous system disease, Spinal cord disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 96-0272831
Code Inist : 002B05C02A. Création : 199608.